Sunday, 27 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q1 FY27

Mukka Proteins Q1 FY27 Results: Net Profit ₹18.6 Cr, Up 1062.5% YoY

Mukka Proteins Ltd reported revenue from operations of ₹489.7 Cr (+186.7% YoY) and net profit of ₹18.6 Cr (+1062.5% YoY) for Q1 FY27.

Q1 FY27 at a glance · ₹ crore
MetricQ1 FY27Q4 FY26Q1 FY26
Revenue from operations489.7380.6170.8
Other income1.615.22.6
Total income491.2395.8173.3
Profit before exceptional items & tax28.328.82.8
Profit before tax27.428.92.4
Net profit18.621.41.6
Operating margin5.6%7.3%1.4%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+1062.50%
Net profit, quarter on quarter-13.10%
Revenue, year on year+186.70%
Operating profit, year on year+13250.00%
Operating profit, quarter on quarter+96.30%
Source

BSE results filing, NSE: MUKKA. Figures extracted from the filing.

Read the filing ↗

Mukka Proteins Ltd: key numbers

Share price
₹27.40
Market cap
₹822.0 Cr
Revenue (annual)
₹1,449 Cr
Net profit (annual)
₹52.06 Cr
P/E (TTM)
11.9×Sector 29.0×
Promoter holding
73.33%+0.00% QoQ
FII holding
1.73%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Mukka Proteins Ltd

All →
22:45 IST BSE
Management Change

Mukka Proteins Management Change

Mukka Proteins Limited announced the re-appointment of six directors to its board, including independent and executive members, each for a five-year term.

22:36 IST NSE
Annual General Meeting

Mukka Proteins Annual General Meeting

Mukka Proteins Limited held its 16th Annual General Meeting on September 10, 2026. The meeting covered financial adoption, director re-appointments, and other routine business.

10:24 IST BSE
Capital Structure Change

Mukka Proteins Capital Structure Change

Mukka Proteins allot 2 Crore convertible warrants to 15 non-promoter investors at Rs. 23.50, raising Rs. 47 Crore. Warrants convert to one equity share in 18 months.

Value
₹47.00 Cr
17:31 IST BSE
Regulatory Approval

Mukka Proteins Regulatory Approval

Mukka Proteins received an 'EU - Inputs Attestation' from ECOCERT S.A.S. for its 'Eco Sphere Organic Fertilizer', validating its suitability for use in organic farming.

Execution
Valid from September 4, 2026, until March 31, 2028
17:23 IST NSE
Business Update

Mukka Proteins Business Update

Mukka Proteins received an EU-Inputs Attestation from ECOCERT S.A.S., France, for its Eco Sphere Organic Fertilizer. This confirms suitability for organic farming, enhancing product marketability.